Promotion of physical activity and mobility among older people with musculoskeletal disorders

Program to Promote Physical Activity and mobility recovery in older people hospitalized for musculoskeletal disorders: A single-centre randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13461584

Enrollment

120

Registered

2016-01-27

Start date

2016-02-01

Completion date

Unknown

Last updated

2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal disorders in lower extremities or back Musculoskeletal Diseases Musculoskeletal disorders in lower extremities or back

Interventions

Participants are randomly allocated to one of two groups. Intervention group: Participants receive standard/usual care, as well as an individually targeted multi-component home-based

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 60 years and over 2. Community-dwelling 3. Admitted and thereafter discharged to home from Health Centre-Hospital because of musculoskeletal disorder, such as orthopedic surgery of lower extremity (i.e. hip fracture, joint replacement) or some other musculoskeletal event or condition of lower extremity or back (i.e. fall, aggravated arthritis, osteoporotic fracture and/or back pain)

Exclusion criteria

Exclusion criteria: 1. Living in an institution 2. Confined to bed at time of recruitment 3. Severe memory problems (mini-mental state examination (MMSE) less than 21 4. Severe cardiovascular or pulmonary disease 5. Severe progressive disease (i.e., neoplasm, ALS, Parkinson disease). 6. Alcoholism 7. Unwillingness to participate

Design outcomes

Primary

Measure	Time frame
1. Level of physical activity and inactivity is objectively assessed using the accelerometer at baseline, 3 and 6 months 2. Level of physical activity is measured using validated self-reporting questionnaires at baseline, 3, 6 and 12 months 3. Mobility is assessed using the Short Physical Performance Battery and self-reporting at baseline, 3, 6 and 12 months	—

Secondary

Measure	Time frame
1. Life space mobility is assessed by Birmingham Life-Space Assessment (LSA) at baseline, 3, 6 and 12 months 2. Social participation and autonomy is assessed using the Impact on Participation and Autonomy (IPA) questionnaire at baseline, 6 and 12 months 3. Fear of falling assessed using the Falls Efficacy Scale International (FES) questionnaire at baseline, 3, 6 and 12 months 4. Pain is assessed using the modified Brief Pain Inventory at baseline, 3, 6 and 12 months 5. Depressive mood assessed is measured using the Centre for Epidemiologic Studies Depression Scale (CES-D) at baseline, 3, 6 and 12 months 6. Perceived barriers to indoor and outdoor physical activity is assessed using checklists for perceived environmental barriers to outdoor mobility (PENBOM; 15 items) and perceived environmental facilitators for outdoor mobility (PENFOM; 16 items) as well as self-reporting at baseline, 3, 6 and 12 months 7. Memory are assessed using Mini-Mental State Examination (MMSE) at baseline, 3, 6 and 12 months 8. Executive function is assessed using the Trail Making test at baseline, 3, 6 and 12 months 9. Use of formal and informal care is assessed through self-reporting (formal health care will be varified from the registers of Health Centre-Hosptials) at 3, 6 and 12 months 9. Hand grip strength from the dominant hand with a hand-held dynamometer at baseline, 3, 6 and 12 months	—

Measure

Time frame

1. Life space mobility is assessed by Birmingham Life-Space Assessment (LSA) at baseline, 3, 6 and 12 months 2. Social participation and autonomy is assessed using the Impact on Participation and Autonomy (IPA) questionnaire at baseline, 6 and 12 months 3. Fear of falling assessed using the Falls Efficacy Scale International (FES) questionnaire at baseline, 3, 6 and 12 months 4. Pain is assessed using the modified Brief Pain Inventory at baseline, 3, 6 and 12 months 5. Depressive mood assessed is measured using the Centre for Epidemiologic Studies Depression Scale (CES-D) at baseline, 3, 6 and 12 months 6. Perceived barriers to indoor and outdoor physical activity is assessed using checklists for perceived environmental barriers to outdoor mobility (PENBOM; 15 items) and perceived environmental facilitators for outdoor mobility (PENFOM; 16 items) as well as self-reporting at baseline, 3, 6 and 12 months 7. Memory are assessed using Mini-Mental State Examination (MMSE) at baseline, 3, 6 and 12 months 8. Executive function is assessed using the Trail Making test at baseline, 3, 6 and 12 months 9. Use of formal and informal care is assessed through self-reporting (formal health care will be varified from the registers of Health Centre-Hosptials) at 3, 6 and 12 months 9. Hand grip strength from the dominant hand with a hand-held dynamometer at baseline, 3, 6 and 12 months

—

Countries

Finland

Contacts

Public ContactKatri Turunen

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026